[Federal Register Volume 62, Number 99 (Thursday, May 22, 1997)]
[Notices]
[Page 28058]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-13526]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Meeting of
the Sickle Cell Disease Advisory Committee
Pursuant to Pub. L. 92-463, notice is hereby given of the meeting
of the Sickle Cell Disease Advisory Committee, National Heart, Lung,
and Blood Institute, June 9, 1997. The meeting will be held at the
National Institutes of Health, Rockledge II, Conference Room 9104, 6701
Rockledge Drive, Bethesda, Maryland 20892.
The entire meeting will be open to the public from 9:00 a.m. to
adjournment, to discuss recommendations on the implementation and
evaluation of the Sickle Cell Disease Program. Attendance by the public
will be limited to space available.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
contact the Executive Secretary in advance of the meeting.
Dr. Clarice D. Reid, Executive Secretary, Sickle Cell Disease
Advisory Committee, Division of Blood Diseases and Resources, NHLBI,
Two Rockledge Center, Suite 10160, 6701 Rockledge Drive, Bethesda,
Maryland 20892, (301) 435-0080, will furnish substantive program
information, a summary of the meeting, and a roster of the committee
members.
(Catalog of Federal Domestic Assistance Program No. 93.839, Blood
Diseases and Resources Research, National Institutes of Health)
Dated: May 19, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-13526 Filed 5-21-97; 8:45 am]
BILLING CODE 4140-01-M
